Skip to main content
VMD
NASDAQ Industrial Applications And Services

Viemed Healthcare Authorizes New 5% Share Repurchase Program and Issues Strong 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$9.97
Mkt Cap
$377.534M
52W Low
$5.93
52W High
$10.06
52W Position info
68% above low
Off High info
at 52W high
Rel. Volume info
3.6× avg
Market data snapshot near publication time

VMD sits 68% above its 52-week low of $5.93 on elevated volume (3.6× avg).

Summary

Viemed Healthcare announced new 2026 financial guidance and authorized a significant new share repurchase program for up to 5% of outstanding shares, signaling continued growth and management confidence.


Key Events · Financing and Capital Events · VMD

  • New 2026 Financial Guidance Issued

    The company provided full-year 2026 guidance, projecting net revenue between $310 million and $320 million, and Adjusted EBITDA between $65 million and $69 million.

  • Significant Share Repurchase Program Authorized

    The Board authorized a new share repurchase program for up to 5% of the company's outstanding shares, following a previous authorization mentioned in the 10-K on March 4, 2026.

  • Strong Financial Performance Continues

    The guidance builds on strong 2025 results, including $270 million in net revenue and $61 million in Adjusted EBITDA, as previously reported in the 10-K on March 4, 2026.


Analysis · VMD · Industrial Applications And Services

Viemed Healthcare's 8-K filing, accompanying an investor presentation, provides new full-year 2026 financial guidance, projecting continued revenue and Adjusted EBITDA growth. Crucially, the company's board has authorized a new share repurchase program for up to 5% of its outstanding shares. This capital allocation decision, following a previous repurchase authorization noted in the recent 10-K, signals management's confidence in the company's valuation and future prospects, especially as the stock trades near its 52-week high. The guidance and repurchase program reinforce the positive outlook established in the recent strong 2025 financial results.

At the time of this filing, VMD was trading at $9.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $377.5M. The 52-week trading range was $5.93 to $10.06. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VMD - Latest Insights

VMD
Jun 04, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.84
Real-time Price: $11.92 info
Change: +$2.08 (+21%) info
Market Cap: $456.975M info
VMD
May 05, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.50
Real-time Price: $11.92 info
Change: +$2.42 (+25%) info
Market Cap: $456.975M info
VMD
May 05, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $9.62
Real-time Price: $11.92 info
Change: +$2.30 (+24%) info
Market Cap: $456.975M info
VMD
Apr 22, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $9.51
Real-time Price: $11.92 info
Change: +$2.41 (+25%) info
Market Cap: $456.975M info
VMD
Mar 20, 2026, 5:06 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $8.63
Real-time Price: $11.92 info
Change: +$3.29 (+38%) info
Market Cap: $456.975M info